Aveva Drug Delivery Systems recalls

Aveva Drug Delivery Systems has 3 recalls on record with the FDA and USDA, the earliest in 2023 and the latest reported on 3 Jun 2026. 1 is still ongoing. 1 was reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls3since 2023

Last 12 months1reported

Class I00% of total

Ongoing1latest 3 Jun 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 1 0 0Aug 0 0

Severity split

Class I 0 0%Class II 0 0%Class III 3 100%

Why aveva drug delivery systems is recalled

Potency & Assay3100%

Product types

Creams, Ointments & Gels133%

By year

2026133%
2023267%

Ongoing aveva drug delivery systems recalls

1 active

Reported	Class	Recall	Company	Reason	Where
3 Jun 2026Drug	CLASS III	Nicotine Transdermal System Patch, 14 mg, 14 patches per, Aveva recalledNicotine	Aveva Drug Delivery Systems	Potency & Assay	Nationwide

All aveva drug delivery systems recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
3 Jun 2026Drug	CLASS III	Nicotine Transdermal System Patch, 14 mg, 14 patches per, Aveva recalledNicotine	Aveva Drug Delivery Systems	Potency & Assay	Nationwide
22 Mar 2023Drug	CLASS III	Buprenorphine Transdermal System, CIII 10 mcg/hour recalled	Aveva Drug Delivery Systems	Potency & Assay	Nationwide
22 Mar 2023Drug	CLASS III	Buprenorphine Transdermal System, CIII 20 mcg/hour recalled	Aveva Drug Delivery Systems	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.